CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Cash flows from operating activities:
Net income	$ 2,609,000	$ 1,885,000
Adjustments to reconcile net income to net cash from operating activities:
Depreciation and amortization	347,000	307,000
Amortization of deferred loan fees	(440,000)	(409,000)
Net amortization of premiums and discounts	42,000	57,000
Write-downs and losses on real estate acquired through foreclosure, net of gains	107,000	44,000
Gain on sale of mortgage loans	(720,000)	(595,000)
Proceeds from sale of mortgage loans held for sale	22,536,000	15,195,000
Originations of loans held for sale	(19,438,000)	(15,873,000)
Stock-based compensation	43,000	56,000
Increase in cash surrender value of bank-owned life insurance	(39,000)	(40,000)
Deferred income taxes	193,000	757,000
Decrease in accrued interest receivable	216,000	186,000
Increase in other assets	(2,721,000)	(328,000)
Increase (decrease) in accrued expenses and other liabilities	2,953,000	(707,000)
Net cash provided by operating activities	5,688,000	535,000
Cash flows from investing activities:
Loan principal repayments, net of (disbursements)	9,087,000	(1,238,000)
Redemption (purchase) of restricted stock investments	910,000	(355,000)
Purchases of premises and equipment, net	(85,000)	(288,000)
Activity in securities held to maturity:
Maturities/calls/repayments	3,095,000	4,356,000
Activity in available-for-sale securities:
Purchases		(2,000,000)
Maturities/calls/repayments	1,000,000	15,000
Proceeds from sales of real estate acquired through foreclosure		122,000
Net cash provided by investing activities	14,007,000	612,000
Cash flows from financing activities:
Net decrease in deposits	(69,633,000)	(12,312,000)
Net increase in short-term borrowings		8,000,000
Additional long-term borrowings		5,000,000
Repayments of long-term borrowings	(25,000,000)	(5,000,000)
Common stock dividends	(382,000)	(367,000)
Preferred stock dividends		(70,000)
Exercise of stock options	81,000	56,000
Net cash used in financing activities	(94,934,000)	(4,693,000)
Decrease in cash and cash equivalents	(75,239,000)	(3,546,000)
Cash and cash equivalents at beginning of period	188,340,000	21,853,000
Cash and cash equivalents at end of period	113,101,000	18,307,000
Supplemental Noncash Disclosures
Interest paid on deposits and borrowed funds	2,490,000	1,872,000
Income taxes paid		$ 12,000
Real estate acquired in satisfaction of loans	171,000
Initial recognition of operating lease right-of-use asset	2,684,000
Initial recognition of operating lease liability	2,684,000
Transfers of loans held for sale to loan portfolio	$ 648,000